Alerts will be sent to your verified email
Verify Email
SHAMROIN
|
Shamrock Indl. Co
|
Saroja Pharma Inds.
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 27.98 % | 10.99 % |
|
5yr average Equity Multiplier
|
1.02 | 4.23 | 1.23 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 2.66 | 0.25 |
|
5yr Avg Net Profit Margin
|
0.0 | 2.05 % | 77.44 % |
|
Price to Book
|
25.24 | 0.0 | 1.6 |
|
P/E
|
0.0 | 8.2 | 28.65 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 72.5 Days | 63.13 Days |
|
Inventory Days
|
0.0 | 9.36 Days | 54.75 Days |
|
Days Receivable
|
0.0 | 145.45 Days | 11.98 Days |
|
Days Payable
|
0.0 | 53.02 Days | 169.78 Days |
|
5yr Average Interest Coverage Ratio
|
0.0 | 2.62 | 820.35 |
|
5yr Avg ROCE
|
-8.65 % | 33.47 % | 17.27 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 4.85 % | -130.11 % |
|
5 yr average Debt to Equity
|
0.0 | 1.55 | 0.0 |
|
5yr CAGR Net Profit
|
-15.95 % | 7.13 % | -26.08 % |
|
5yr Average Return on Assets
|
-8.47 % | 5.43 % | 8.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.36 % | 73.02 % | 59.53 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.38 % | 0.0 | 0.45 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shamrock Indl. Co
|
Saroja Pharma Inds.
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|